Clinical Trial Update: Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

This document is a clinical trial update on the use of adipose-derived regenerative cells to treat critical limb ischemia in Phase 1/2, with the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetic Angiopathy
• Peripheral Arterial Disease
• Thromboangiitis Obliterans

Drugs mentioned

• Adipose-derived Regenerative Cells (Adipose-derived Regenerative Cells)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Critical Limb Ischemia, Arteriosclerosis Obliterans | Phase 1, Phase 2 | Status: UNKNOWN